panasonic's Message History
Replies
Messages Posted
My rated Messages
Biocon
Reply By  Khan
Date: 22nd Mar, 2010 - 13:43
BSE: Rs 285.00 ( 1.12 % ), NSE: Rs. 284.75 ( 1.12 % )
Addressed to mylo, aajkavyapar, aditya13556, Ajay.IDBI, akashpandit, alifiya786, aloka27, les, Dakshina murthy, athina, bagram, basit222, Be and Make, BullSheetRules, Callahan, champzeero, chief_kamani, dintak, dipakgod, fdm, karshin, fundoobull1, galarajesh, Cool Bull, guli, neeguya, gvananthaswamy, mep1, headstead, hsnmf, ISHANT, j2eeprofessiona, jagishar, INOU, patience, jonas, kiki chatterjee, kinchit s mehta, man, mindnmoney, mohankumar1000, mukut, naugtyboy, netdo, panasonic, pandumanu, bihariboy, pkumar73, pms.swastika, ppsiras, PK675, marketman, passsion2excel, pranky, pravingp, pss5588, NAUGHTY007, radhika_nandlal, StockTips, manjyot, rohitjust5u, rvk41, minku123, SAJIMON-PALAI, sameernics, Sason, srbhj, KotakInvestment, bookworm, shareware78, simmi123, skshare, tibusa, TrueCompanion, valuerupee, Varner, tara23, q7, vuppala1948, sam_pd, WWIL, Zorro555
AFTER a poor show in earnings for the fiscal year 2009, India’s leading biotech company Biocon has registered a good recovery in the current fiscal.
With traction in its biopharma business and an improvement in the performance of its German subsidiary, Axicorp, the company holds attractive growth opportunities going forward. It is a good bet for investors interested in the mid-cap space.
BUSINESS:
The Bangalorebased company develops and manufacturers bio-pharmaceutical products for various medical ailments including cancer, diabetes and inflammatory diseases. The company’s biopharma business model straddles both products and services.
The company’s statins business, which contributes nearly 30% to its revenues, has witnessed a strong growth in revenues. Further, the biopharma business has also gained from growth in domestic formulations business, insulins and immunosuppressants.
Axicorp, the company’s low-margin trading business, has showed improvement and the subsidiary is gaining from supplying to the tender floated by the German insurer AOK. Through its two subsidiaries, Syngene and Clinigene, the company provides end-to-end services from pre-clinical discovery research to human clinical trials. It contributes nearly 15% to the company’s revenues.
Biocon is also working on product development in view of the opportunity of launching biosimilars in the US and other regulated markets. The company has been steadily increasing spend on R&D . It now spends 7.5% of its revenues on R&D .
FINANCIALS:
The company’s net sales have grown at a compound annual growth rate (CAGR) of 24.4% over the past five fiscal years to reach around Rs 1,608.7 crore in FY09. The net profits have rather grown in an erratic manner during the same period. Heavy MTM losses, high depreciation due to large capex and rise in interest costs put pressure on net profit in the recent past. Despite this, the company has been consistently paying dividend for the past six years.
It has incurred high capex over the past three years. As the company’s big-ticket capex are over, it is expected to generate more free cash flows going forward. However, the fact that the company earns majority of its revenues from lowmargin business segments of statins and Axicorp remains a concern.
GROWTH OPPORTUNITIES:
The patent for Atorvastatin is expiring in the UK in 2010 and in Germany in 2011 offering opportunity for the company to tap the -billion market . Given the increasing trend of R&D outsourcing, the company’s contract research service business is likely to see strong earnings inflow in the coming years. Strong ramp up in the scale and number of projects under Syngene are likely to augur near-term growth.
Launch of biosimilars in regulated markets and commercialisation of its oral insulin programme IN-105 are long-term growth drivers for the company. A possible listing of its subsidiary, Syngene , could lead to value unlocking for the company and its shareholders.
VALUATIONS:
The company’s stock has been outperforming the Sensex since the middle of 2009. It is currently trading at a consolidated price-to-earnings value of 23. It is valued at two-and-a-half times its net sales. These valuations come on the back of promising growth prospects of the company across its various business segments. Investors with a long-term horizon are likely to benefit from the company’s promising growth story. ...
Addressed to mylo, aajkavyapar, aditya13556, Ajay.IDBI, akashpandit, alifiya786, aloka27, les, Dakshina murthy, athina, harshadketan, bagram, basit222, Be and Make, bharat in delhi, BullSheetRules, bull_ramson, Callahan, champzeero, chief_kamani, chokksin, dakuamma, dintak, dipakgod, fdm, karshin, fundoobull1, galarajesh, gajabhau, guli, neeguya, mep1, headstead, hsnmf, ISHANT, j2eeprofessiona, jagishar, INOU, patience, jonas, kiki chatterjee, kinchit s mehta, knpnortho, mannish, mindnmoney, mohankumar1000, mukut, naugtyboy, netdo, nitchakal, nkgambhir, alkatiwari, panasonic, pandumanu, pcspune, pkumar73, pms.swastika, poorfellow, ppsiras, PK675, marketman, passsion2excel, pranky, pravingp, prjayachandran, pss5588, NAUGHTY007, radhika_nandlal, StockTips, ramakar, GOLD FINGER, manjyot, roameri, rohitjust5u, rvk41, minku123, sameernics, Sason, srbhj, subasu, KotakInvestment, bookworm, shareware78, skshare, tibusa, tonyreb, TrueCompanion, valuepick, valuerupee, Varner, tara23, q7, vuppala1948, eagle's eye, winwath, sam_pd, WWIL, Zorro555
Chief, i am not much worried about rate hike.It seems that more than the markets,the analysts in cnbc is more worried about rate hikes.Don`t blame them , they have to run their shop.,IN 2008 when the market was at 21000 ,the repo rate was at 7.75%.Now even after the increase it is 5% only.A lot of room still left for upmove.I am not worried about inflation also.We can not keep the rate of of rice and onion at rs.5 forever.Let it increase and let the farmers also make some money.Think about inclusive growth.,In 80`s a cup of tea was sold at 10 paise per cup.Now it is 5 rs.per cup.How many of us stopped drinking tea because of this.,In US the same cup of tea is sold for 50 rs(converted to INR).When we start selling tea at rs.50 we will be called a `SUPER POWER`...
Addressed to aajkavyapar, aditya13556, Ajay.IDBI, akashpandit, alifiya786, aloka27, les, Dakshina murthy, athina, harshadketan, bagram, Be and Make, bharat in delhi, bhusbhac, BullSheetRules, bull_ramson, Callahan, champzeero, chief_kamani, chokksin, nadhi, dakuamma, dipakgod, karshin, fundoobull1, galarajesh, gajabhau, guli, neeguya, gvananthaswamy, mep1, headstead, hsnmf, ISHANT, j2eeprofessiona, jagishar, INOU, patience, jonas, kalpataru70, LEO THE LION, mindnmoney, mohankumar1000, mukut, naugtyboy, netdo, nitchakal, alkatiwari, panasonic, pandumanu, bihariboy, pkumar73, pms.swastika, poorfellow, ppsiras, passsion2excel, pranky, pravingp, prjayachandran, pss5588, NAUGHTY007, radhika_nandlal, StockTips, ramakar, GOLD FINGER, manjyot, roameri, rohitjust5u, rvk41, minku123, SAJIMON-PALAI, sameernics, Sason, srbhj, subasu, KotakInvestment, bookworm, shareware78, skshare, sondeep_sisotee, tibusa, tonyreb, BAnil, TrueCompanion, valuepick, valuerupee, Varner, tara23, q7, vuppala1948, eagle's eye, winwath, sam_pd, WWIL, Zorro555
MOVING WITH THE LEVELS NIFTY HITS INTRA DAY HIGH OF 5269.95 FINALLY CLOSED AT 5262.80
REGARDS,
Manish Bothra,
Money_Mystery,
Kolkata...
Addressed to aajkavyapar, Abhay Kulkarni, adaljaarun, aditya13556, aidas1234, Ajay.IDBI, akashpandit, alifiya786, aloka27, les, Dakshina murthy, athina, harshadketan, bagram, Be and Make, bharat in delhi, bhusbhac, BullSheetRules, bull_ramson, Callahan, capitalm, champzeero, chief_kamani, chokksin, CompletelyWrong, nadhi, dakuamma, dintak, dipakgod, karshin, fundoobull1, galarajesh, gajabhau, guli, gvananthaswamy, mep1, headstead, hsnmf, ISHANT, j2eeprofessiona, jagishar, INOU, patience, jonas, kalpataru70, man, mindnmoney, mohankumar1000, mukut, naugtyboy, netdo, nitchakal, nkgambhir, alkatiwari, panasonic, pandumanu, ADAG ROCKS, bihariboy, pkumar73, pms.swastika, poorfellow, marketman, passsion2excel, pranky, pravingp, prjayachandran, pss5588, NAUGHTY007, radhika_nandlal, StockTips, ramakar, GOLD FINGER, manjyot, roameri, rohitjust5u, rvk41, minku123, SAJIMON-PALAI, sameernics, Sason, srbhj, subasu, KotakInvestment, bookworm, shareware78, skshare, sondeep_sisotee, FirstIndian, tibusa, tonyreb, BAnil, TrueCompanion, valuerupee, Varner, tara23, vuppala1948, eagle's eye, winwath, sam_pd, Zorro555
Dear All,
Its ShoCkInG!!!!
Today my Stock Idea message on Century Ply got vanished/deleted from the message board.....its Disgusting....Why so happened??????
Today morning I posted a Stock Idea call on Century Ply and the message was@
STOCK IDEA@ CENTURY PLY LOOKS GOOD ONLY ABOVE 55 FOR A TARGET OF UPTO 59-61. AVOID ANY LONG BELOW 55.
After an hour or so the Target got HIT where it hits a high of 59.40 from the odd 55 levels.
How can they remove my message from the message board?? Its SHAMEFUL on the part of message board management!!! Its an UGLY act afterall!!!
Kind Regards,
Manish Bothra,
Kolkata.
...
CenturyPlyboard
Reply By  mannish
Date: 18th Mar, 2010 - 22:49
BSE: Rs 54.95 ( 1.85 % ), NSE: Rs. 55.00 ( 2.23 % )
Addressed to aajkavyapar, Abhay Kulkarni, adaljaarun, aditya13556, aidas1234, akashpandit, alifiya786, aloka27, les, Dakshina murthy, athina, harshadketan, bagram, Be and Make, bharat in delhi, bhusbhac, BullSheetRules, bull_ramson, Callahan, capitalm, champzeero, chief_kamani, chokksin, CompletelyWrong, nadhi, dakuamma, dintak, dipakgod, karshin, fundoobull1, galarajesh, gajabhau, guli, gvananthaswamy, mep1, headstead, hsnmf, ISHANT, j2eeprofessiona, jagishar, INOU, patience, jonas, kalpataru70, man, mindnmoney, mohankumar1000, mukut, naugtyboy, netdo, nitchakal, nkgambhir, alkatiwari, panasonic, pandumanu, ADAG ROCKS, bihariboy, pkumar73, pms.swastika, poorfellow, marketman, passsion2excel, pranky, pravingp, prjayachandran, pss5588, NAUGHTY007, radhika_nandlal, StockTips, ramakar, GOLD FINGER, manjyot, roameri, rohitjust5u, rvk41, minku123, SAJIMON-PALAI, sameernics, Sason, srbhj, subasu, KotakInvestment, bookworm, shareware78, skshare, sondeep_sisotee, FirstIndian, tibusa, tonyreb, BAnil, TrueCompanion, urfool, valuerupee, Varner, tara23, vuppala1948, eagle's eye, winwath, sam_pd, Zorro555
Dear All,
My Stock Idea message on Century Ply got vanished/deleted from the message board.....its Disgusting....Why so happened??????
Today morning I posted a stock idea call on Century ply and the message was@
STOCK IDEA@ CENTURY PLY LOOKS GOOD ONLY ABOVE 55 FOR A TARGET OF UPTO 59-61. AVOID ANY LONG BELOW 55.
After an hour or so the Target got HIT where it hits a high of 59.40 from the odd 55 levels.
How can they remove my message from the message board?? Its SHAMEFUL on the part of message board management!!! Its an UGLY act afterall!!!
Kind Regards,
Manish Bothra,
Money_Mystery,
Kolkata.
...
CenturyPlyboard
Reply By mannish
Date: 18th Mar, 2010 - 12:13
BSE: Rs 58.00 ( 7.51 % ), NSE: Rs. 57.45 ( 6.78 % )
Addressed to Udayan Mukherjee, aajkavyapar, Abhay Kulkarni, adaljaarun, aditya13556, akashpandit, alifiya786, aloka27, les, Dakshina murthy, annupilli, harshadketan, bagram, Be and Make, bharat in delhi, bhusbhac, BullSheetRules, bull_ramson, Callahan, capitalm, chief_kamani, chokksin, CompletelyWrong, nadhi, dakuamma, dipakgod, karshin, fundoobull1, galarajesh, guli, gvananthaswamy, mep1, hansal77, headstead, hsnmf, ISHANT, j2eeprofessiona, jagishar, INOU, patience, jonas, kalpataru70, mindnmoney, mohankumar1000, naugtyboy, netdo, nkgambhir, panasonic, pandumanu, ADAG ROCKS, bihariboy, pkumar73, pms.swastika, poorfellow, ppsiras, marketman, pravingp, pss5588, NAUGHTY007, radhika_nandlal, StockTips, GOLD FINGER, manjyot, rohitjust5u, rvk41, SAJIMON-PALAI, sameernics, Sason, srbhj, subasu, KotakInvestment, bookworm, shareware78, skshare, sondeep_sisotee, FirstIndian, tibusa, tonyreb, BAnil, TrueCompanion, valuepick, Varner, tara23, vuppala1948, eagle's eye, winwath, sam_pd
Alert@ CENTURY PLY HITS 59.40 ON THE HIGHER SIDE SO FAR
regards,
Manish Bothra,
Money Mystery Sms,
Kolkata....
Addressed to aajkavyapar, Abhay Kulkarni, adaljaarun, aditya13556, akashpandit, aloka27, les, Dakshina murthy, annupilli, athina, harshadketan, bagram, Be and Make, bharat in delhi, bhusbhac, BullSheetRules, bull_ramson, Callahan, capitalm, champzeero, chief_kamani, CompletelyWrong, nadhi, dipakgod, karshin, fundoobull1, gajabhau, guli, neeguya, gvananthaswamy, mep1, hansal77, headstead, hsnmf, ISHANT, j2eeprofessiona, jagishar, INOU, patience, jonas, kalpataru70, kumashish, man, mindnmoney, mohankumar1000, mukut, naugtyboy, netdo, nitchakal, nkgambhir, alkatiwari, panasonic, pandumanu, ADAG ROCKS, bihariboy, pkumar73, pms.swastika, poorfellow, ppsiras, marketman, passsion2excel, pranky, pravingp, pss5588, NAUGHTY007, radhika_nandlal, StockTips, GOLD FINGER, manjyot, roameri, rohitjust5u, rvk41, minku123, SAJIMON-PALAI, sameernics, Sason, srbhj, subasu, KotakInvestment, bookworm, shareware78, skshare, sondeep_sisotee, FirstIndian, tibusa, tonyreb, BAnil, TrueCompanion, valuepick, Varner, tara23, vuppala1948, eagle's eye, winwath, sam_pd, Zorro555
Washington, Feb 04 (ANI): Asthma patients using herbal remedies may make their quality of life worse and suffer from increased frequency of symptoms, a new study claims.
A study conducted by American College of Allergy, Asthma and Immunology observed 326 asthma patients over a 33-month period.
Of those, 25 percent reported herbal remedy use and lower adherence to use of prescribed inhaled corticosteroids (ICS).
It was learnt that patients using herbal remedies were more likely to have been hospitalized or intubated for asthma.
Also, they had concerns about possible adverse effects of ICS and difficulty following a medication schedule.
Angkana Roy, M.D., lead author, Department of Pediatrics, Mount Sinai School of Medicine, New York, said: "Results indicate patients using herbal remedies are less likely to take their prescribed medications.
"These patients report worse asthma control and poorer quality of life than patients who follow medication plans. Underuse of prescribed medication is one of the main factors contributing to poor outcomes in asthma patients."
Also, Leonard Bielory, M.D., ACAAI Integrative Medicine Committee chair, added: "Patients interested in herbal remedies need to use them to complement treatment and not as an alternative, or they will not maximize their health and may actually hinder it as this study shows.
"Remember, asthma is a serious disease and needs to be treated that way. Always ask your allergist about medication concerns and discuss use of herbal remedies."
The study has been published in Annals of Allergy, Asthma and Immunology, the scientific journal of ACAAI. (ANI)
...
Stocks seesawed in morning trading Friday as investors hesitated after pushing the Dow, S&P 500 and Nasdaq composite to 18-month highs in the previous session...
TILAKNAGAR SHORT TERM TARGET 150.
Posted by : panasonic
Price when posted : BSE: Rs 120.05 ( 6.90 % )View full discussion
Alert!!!!!!!!!!!!
Posted by : panasonic
Price when posted : BSE: Rs 114.00 ( 1.51 % )View full discussion
If it sustain above 110 than next target will be 152, and in next two years 400+... ...
...
Cairn India
Posted by : panasonic
Date :17th Mar, 2010 - 21:10
BSE: Rs 279.55 ( -0.46 % ), NSE: Rs. 279.60 ( -0.64 % )
Dow touches new 2010 high
Stocks gained Wednesday, with the Nasdaq and S&P 500 building on 18-month highs hit in the previous session, as investors continued to welcome the Federal Reserve`s decision to hold interest rates steady.
...
Dow touches new 2010 high
Stocks gained Wednesday, with the Nasdaq and S&P 500 building on 18-month highs hit in the previous session, as investors continued to welcome the Federal Reserve`s decision to hold interest rates steady.
...
Stocks ended little changed Friday, as investors welcomed a report that showed a surprise rise in retail sales, but showed caution as the Dow, Nasdaq and S&P 500 lingered below 18-month highs.
...
NEW YORK -- U.S. stocks were poised to rise at Wednesday`s open, as investors signaled optimism about the economy a day after the Federal Reserve, as expected, said it would keep rates low for an extended period.
Dow Jones industrial average, S&P 500 and Nasdaq 100 futures were higher ahead of the opening bell....
U.S. stocks were poised to rise at Wednesday`s open, amid optimism over the Federal Reserve`s decision to keep rates low for an extended period.
...
Oil and gold: The price of oil rose $1.06 per barrel to $80.86. The price of gold rose $18.30 per ounce to $1,123.40. ...
The Cairn India-ONGC JV has initiated exploration in its Gujarat-Saurashtra basin block. "The JV has received environment ministry
clearance for initiating exploration following a positive environmental impact assessment (EIA) report in the NELP-V block. It will be allowed to drill one well in the west coast block during 2010," a senior petroleum ministry source familiar with the project told said.
The Gujarat-Saurashtra basin block (GS-OSN-2003/1) is 51% owned by ONGC while Cairn India owns the balance 49%. The JV partners had sought environment clearance for the block, which is over 12 nautical miles away from the west coast. The MoEF said that if commercial viability of the Gujarat-Saurashtra project is established, the operator will be required to prepare a detailed plan for development of oil and gas fields and obtain a fresh environmental clearance.
Cairn India has launched seismic surveys in a number of its other blocks. It has also undertaken 4D seismic survey at Ravva. Cairn India has also launched 3D seismic surveys in Palar basin and in Sri Lanka.
...
After the doom and gloom of 2008 and heady gains of 2009, experts think next year might be a calm, boring one for stocks. There`s nothing wrong with that....
torrent power ( SURAT ) for 67 now 325. ...
|
Online
Popular Boarders 7days
|
Connect.in.com | Budget: 2008, 2009, 2010